RAS/PI3K promotes the expression of angiogenic factors, e.g., vascular endothelial growth factor A (VEGFA), via cyclooxygenase 2 (COX2) (44) and activation of tumor angiogenesis and coagulation pathways leads to adaption to sotorasib (45). Here, PTGS2 is linked to neoplasm.